Diana Paredes-Ruiz

8PUBLICATIONS
19CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Rheumatology and arthritisRegenerative medicine (incl. stem cells)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 20, 2026
Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity.

|Apr 22, 2026
Efficacy of the Lupus-Cruces Nephritis protocol in different prognostic groups: a propensity score and cluster analysis.

|May 27, 2025
Long-term efficacy and safety of the Lupus-Cruces Nephritis protocol: a propensity score study of the Lupus-Cruces and Lupus-Bordeaux cohorts.

|Oct 26, 2024
No Effect of Low-Dose Glucocorticoid Maintenance Therapy on Damage in SLE Patients in Prolonged Remission: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort.

Guillermo Ruiz-Irastorza, Diana Paredes-Ruiz, Luis Dueña-Bartolome

|Mar 26, 2024
Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort.

Guillermo Ruiz-Irastorza, Diana Paredes-Ruiz, Maria Herrero-Galvan

|Dec 19, 2023
Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus.

Diana Paredes-Ruiz, Daniel Martin-Iglesias, Guillermo Ruiz-Irastorza

Pageof 2

Frequent Collaborators

5 joint publications

Guillermo Ruiz-Irastorza

3 joint publications

Luis Dueña-Bartolomé

3 joint publications

Estibaliz Lazaro

3 joint publications

Víctor Moreno-Torres